Pancreatic cancer is characterized by genomic complexity and instability; telomere shortening, loss of TP53, K-RAS mutation, abnormal mitosis and nuclear abnormalities are all contributors to this phenotype [17]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.